Literature DB >> 33144717

FDA approves antibody cocktail for Ebola virus.

Asher Mullard.   

Abstract

Entities:  

Year:  2020        PMID： 33144717     DOI： 10.1038/d41573-020-00197-8

Source DB:  PubMed          Journal:  Nat Rev Drug Discov        ISSN： 1474-1776            Impact factor:   84.694


× No keyword cloud information.
  5 in total

1.  Computational Construction of a Single-Chain Bi-Paratopic Antibody Allosterically Inhibiting TCR-Staphylococcal Enterotoxin B Binding.

Authors:  Ganggang Bai; Yanhong Ge; Yuhong Su; Shuo Chen; Xingcheng Zeng; Huixia Lu; Buyong Ma
Journal:  Front Immunol       Date:  2021-11-23       Impact factor: 7.561

2.  Pharmacologically induced endolysosomal cholesterol imbalance through clinically licensed drugs itraconazole and fluoxetine impairs Ebola virus infection in vitro.

Authors:  Susann Kummer; Angelika Lander; Jonas Goretzko; Norman Kirchoff; Ursula Rescher; Sebastian Schloer
Journal:  Emerg Microbes Infect       Date:  2022-12       Impact factor: 7.163

3.  Remdesivir is efficacious in rhesus monkeys exposed to aerosolized Ebola virus.

Authors:  Travis K Warren; Christopher D Kane; Jay Wells; Kelly S Stuthman; Sean A Van Tongeren; Nicole L Garza; Ginger Donnelly; Jesse Steffens; Laura Gomba; Jessica M Weidner; Sarah Norris; Xiankun Zeng; Roy Bannister; Tomas Cihlar; Sina Bavari; Danielle P Porter; Patrick L Iversen
Journal:  Sci Rep       Date:  2021-09-30       Impact factor: 4.996

4.  Cross-Neutralizing Breadth and Longevity Against SARS-CoV-2 Variants After Infections.

Authors:  Yukiya Kurahashi; Silvia Sutandhio; Koichi Furukawa; Lidya Handayani Tjan; Sachiyo Iwata; Shigeru Sano; Yoshiki Tohma; Hiroyuki Ohkita; Sachiko Nakamura; Mitsuhiro Nishimura; Jun Arii; Tatsunori Kiriu; Masatsugu Yamamoto; Tatsuya Nagano; Yoshihiro Nishimura; Yasuko Mori
Journal:  Front Immunol       Date:  2022-02-24       Impact factor: 7.561

Review 5.  Sagacious epitope selection for vaccines, and both antibody-based therapeutics and diagnostics: tips from virology and oncology.

Authors:  Samuel Ken-En Gan; Ser-Xian Phua; Joshua Yi Yeo
Journal:  Antib Ther       Date:  2022-02-21
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.